ConductScience.org, home

Trial · NCT00301262

Registered outcomes49

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryErectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8)Week 8adjusted mean : Possible scores for the EDITS Index range from 0 (extremely low treatment satisfaction) to 100 (extremely high treatment satisfaction).
SecondaryErectile Dysfunction Inventory of Treatment Satisfaction (EDITS) IndexWeek 8, Week 14Possible scores for the EDITS Index range from 0 (extremely low treatment satisfaction) to 100 (extremely high treatment satisfaction).
SecondaryChange From Baseline to End of Double-Blind Phase (Week 8) in Patient Reported Erectile Function Assessment (PREFA) Total ScoreWeek 8adjusted mean change; PREFA Total Score: 8 = worst; 32 = best.
SecondaryPatient Reported Erectile Function Assessment (PREFA) Total ScoreWeek 8, Week 14PREFA Total Score: 8 = worst, 32 = best.
SecondaryChange From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Erectile FunctionWeek 8adjusted mean change - Possible total scores for IIEF-EF range from 1 (worst) to 30 (best).
SecondaryChange From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Orgasmic FunctionWeek 8adjusted mean change - Possible total scores for IIEF-OF range from 0 (worst) to 10 (best).
SecondaryChange From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Sexual DesireWeek 8adjusted mean change - Possible total scores for IIEF-SD range from 2 (worst) to 10 (best).
SecondaryChange From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Intercourse SatisfactionWeek 8adjusted mean - Possible total scores for IIEF-IS range from 0 (worst) to 15 (best).
SecondaryChange From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Overall SatisfactionWeek 8adjusted mean change - Possible total scores for IIEF-OS range from 2 (worst) to 10 (best).
SecondaryInternational Index of Erectile Function (IIEF) Domain Scores- Erectile FunctionWeek 8, Week 14Possible total scores for IIEF-EF range from 1 (worst) to 30 (best).
SecondaryInternational Index of Erectile Function (IIEF) Domain Scores- Orgasmic FunctionWeek 8, Week 14Possible total scores for IIEF-OF range from 0 (worst) to 10 (best).
SecondaryInternational Index of Erectile Function (IIEF) Domain Scores- Sexual DesireWeek 8, Week 14Possible total scores for IIEF-SD and IIEF-OS range from 2 (worst) to 10 (best).
SecondaryInternational Index of Erectile Function (IIEF) Domain Scores- Intercourse SatisfactionWeek 8, Week 14Possible total scores for IIEF-IS range from 0 (worst) to 15 (best).
SecondaryInternational Index of Erectile Function (IIEF) Domain Scores- Overall SatisfactionWeek 8, Week 14Possible total scores for IIEF-SD and IIEF-OS range from 2 (worst) to 10 (best).
SecondaryChange From Baseline to End of DB Phase (Week 8) in Erectile Distress Scale (EDS) Total ScoreWeek 8adjusted mean change - Possible total scores for EDS range from 5 (all of the time) to 30 (none of the time). Higher scores indicate less impact of ED.
SecondaryErectile Distress Scale (EDS) Total ScoreWeek 8, Week 14Possible total scores for EDS range from 5 (all of the time) to 30 (none of the time). Higher scores indicate less impact of ED.
SecondaryChange From Baseline to End of DB Phase (Week 8) in Quality of Erection Questionnaire (QEQ) Total ScoreWeek 8
adjusted mean change - QEQ raw total score (defined as the sum of scores from QEQ Questions 1 and 3 to 7 and ranged from 6 to 30) was transformed to QEQ total score on a scale of 0 (lowest) to 100 (highest).
SecondaryQuality of Erection Questionnaire (QEQ) Total ScoreWeek 8, Week 14QEQ raw total score (defined as the sum of scores from QEQ Questions 1 and 3 to 7 and ranged from 6 to 30) was transformed to QEQ total score on a scale of 0 (lowest) to 100 (highest).
SecondaryGlobal Efficacy Question 1 (GEQ1) Response at End of the Double-Blind Phase (Week 8) and at End of the Open-Label Phase (Week 14)Week 8, Week 14
GEQ 1: Compared to having no treatment at all for your erection problem, has the medication you have been taking over the past 4 weeks improved your erections?Responder was defined as answering "Yes". % of responders/non-responders was calculated based on subjects who attempted intercourse.
SecondaryGlobal Efficacy Question 2 (GEQ2) Response at End of the Double-Blind Phase (Week 8) and at End of the Open-Label Phase (Week 14)Week 8, Week 14
GEQ 2: Compared to having no treatment at all for your erection problem, has the medication you have been taking over the past 4 weeks improved your ability to have sexual intercourse? Responder was defined as answering "Yes". % of responders/non-responders was calculated based on subjects who attempted intercourse.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00301262/registered